Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06268015
Title Botensilimab and Balstilimab Optimization in Colorectal Cancer (BBOpCo)
Acronym BBOpCo
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nicholas DeVito, MD
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.